Ilyang, Merck sign MOU over ilaprazole
Published: 2009-05-28 06:57:00
Updated: 2009-05-28 06:57:00
Ilyang Pharm and Merck India signed a memorandum of understanding to supply ilaprazole, a new anti-peptic ulcer drug, in its raw material form, to India for the next 10 years on an exclusive basis, it was announced on May 25.
Under the agreement, Merck India will obtain the exclusive right to ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
